The Demise Of A Once Promising Pancreatic Cancer Drug Is All Too Common

It was a Cinderella story from the start. Two enterprising Harvard students, Nathaniel Brooks Horwitz and Nikita Shah, linked up with Harvard Professor Marc Kirschner, on an approach to treating pancreatic cancer. Kirschner’s groundbreaking research was based on a regulatory protein called “Hippo” which was key in preventing cancer drugs from working.